Gainers
- China SXT Pharmaceuticals SXTC stock rose 10.9% to $0.6 during Tuesday's after-market session. The market value of their outstanding shares is at $9.2 million.
- Universe Pharmaceuticals UPC shares moved upwards by 8.69% to $1.75. The company's market cap stands at $38.0 million.
- Genfit GNFT shares increased by 8.07% to $5.49. The company's market cap stands at $251.1 million.
- NeoGenomics NEO shares rose 5.55% to $34.38. Trading volume for this security closed at 71.9K, accounting for 7.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.2 billion.
- Zosano Pharma ZSAN stock rose 4.48% to $0.52. The company's market cap stands at $61.5 million.
- Brooklyn BTX shares moved upwards by 4.41% to $4.73. The market value of their outstanding shares is at $246.1 million.
Losers
- Genocea Biosciences GNCA shares declined by 4.9% to $1.16 during Tuesday's after-market session. The market value of their outstanding shares is at $66.6 million.
- Conformis CFMS stock decreased by 4.62% to $0.74. The market value of their outstanding shares is at $137.7 million.
- Artelo Biosciences ARTL stock declined by 4.16% to $0.54. The market value of their outstanding shares is at $22.8 million.
- POINT Biopharma Global PNT shares declined by 2.95% to $5.6. The company's market cap stands at $504.6 million.
- Viveve Medical VIVE stock declined by 2.61% to $1.12. The market value of their outstanding shares is at $11.8 million.
- Ensysce Biosciences ENSC stock fell 2.49% to $4.32. At the close, Ensysce Biosciences's trading volume reached 65.1K shares. This is 1.0% of its average volume over the last 100 days. The company's market cap stands at $104.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in